We are pleased to announce that the Shackleton team has invested in Hibergene Diagnostics.   The company develops, manufactures and markets molecular diagnostic tests for human infectious diseases, using LAMP (Loop Mediated Isothermal Amplification) technology.

HiberGene is developing its next generation devices to disrupt the established time-consuming and high skilled testing market.  Its devices offer:

  • Testing at front line medical centres;
  • Real-time, accurate results within 60 minutes;
  • Less than 10 minutes preparation time;
  • Minimal training and equipment requirements;
  • A single portable, battery-operated machine for 12 of the most common infectious diseases